Open AccessPersonalized Medicine: A Review
Author(s) -
Sayali R. Gajare,
Amol S. Deshmukh,
Chetana K. Shinde
Publication year - 2021
Publication title -
international journal of pharmaceutical sciences review and research
Language(s) - English
Resource type - Journals
ISSN - 0976-044X
DOI - 10.47583/ijpsrr.2021.v69i01.023
Subject(s) - personalized medicine , medicine , precision medicine , clinical trial , genomics , drug development , disease , translational medicine , health care , drug , intensive care medicine , bioinformatics , pharmacology , genome , pathology , genetics , gene , economics , biology , economic growth
The goal of personalized medicine is to maximize the therapeutic efficacy and to attenuate the threat of drug toxicity for an individual patient. It shows right drug & dose, right patient and at right time administration of a medication. Personalized medicine focuses on individualized drug treatment according to each patient’s genetic makeup as well as molecular diagnosis. Genomics have the power to improve the target selectivity of drugs, the selection of volunteers and patients for clinical trials and hence the chance for success of many agents in specific populations and individuals, which is the key promise of personalized medicine. The main aim of this study is to evaluate the personalized medicine about its indications and benefits, its issues and health care implications. Future perspectives as well as actual clinical applications. Personalized medicine promises prediction, prevention and treatment of illness that is targeted to individuals ‘needs. Translational genetics and genomics research have led to the development of powerful tools for clinical diagnosis, assessing individual’s genomic profile for disease prediction/prevention, high-throughput genome-wide screening for predisposition or protection to complex medical conditions, and development of vaccines and new drugs.